Letters to the Editor
St. John's wort
- Aust Prescr 2000;23:5-5
- 1 January 2000
- DOI: 10.18773/austprescr.2000.007
The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.
Editor, – I enjoyed reading Professor Mitchell's article on Hypericum perforatum, 'St. John's wort - quack medicine or novel antidepressant treatment?' (Aust Prescr 1999;23:112-3). It is nice to see some openness about herbal medicine in the medical profession. I would like to comment on hyperforin, one of the active ingredients in hypericum. It is true that studies have confirmed the antidepressant activity of hyperforin, however, this compound is very unstable, especially during the drying process of the herb, hence it is unlikely that the extracts which have been shown to be effective in many different clinical trials contained any hyperforin. Yet they worked. The hypericums may not have antidepressant activity in their isolated form, however one study has shown that oligomeric procyanidins (OPCs) are necessary for the bioavailability of hypericum. Hypericum extracts are now being marketed which are standardized to both hypericum and hyperforin, however these are only marker compounds for quality control. When the whole herb extract is used, St. John's wort is a safe and effective medicine for depression, anxiety and tension.
South Hobart, Tas.